Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study

M. V. T. Krishna Mohan, Arpitkumar Prajapati, Rushabh Kothari, Srikrishna Mandal, Ranganatha Rao Srikanth, Rajnish Nagarkar, Shriram Khane, Ayyagari Santa, Disha Dadke

Open source

DOI: 10.1007/s40261-024-01374-y
Published: 2024-06-27
Container: Clinical Drug Investigation
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40261-024-01374-y,
  title = {Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study},
  author = {M. V. T. Krishna Mohan and Arpitkumar Prajapati and Rushabh Kothari and Srikrishna Mandal and Ranganatha Rao Srikanth and Rajnish Nagarkar and Shriram Khane and Ayyagari Santa and Disha Dadke},
  year = {2024},
  journal = {Clinical Drug Investigation},
  doi = {10.1007/s40261-024-01374-y},
  url = {https://doi.org/10.1007/s40261-024-01374-y}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study
AU  - M. V. T. Krishna Mohan
AU  - Arpitkumar Prajapati
AU  - Rushabh Kothari
AU  - Srikrishna Mandal
AU  - Ranganatha Rao Srikanth
AU  - Rajnish Nagarkar
AU  - Shriram Khane
AU  - Ayyagari Santa
AU  - Disha Dadke
PY  - 2024
JO  - Clinical Drug Investigation
DO  - 10.1007/s40261-024-01374-y
UR  - https://doi.org/10.1007/s40261-024-01374-y
ER  -

APA

Mohan, M. V. T. K., Prajapati, A., Kothari, R., Mandal, S., Srikanth, R. R., Nagarkar, R., Khane, S., Santa, A., & Dadke, D. (2024). Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01374-y

Source records

crossref · retrieved 2026-09-25T10:24:54.978Z